P70 S6 kinase assay: a pharmacodynamic monitoring strategy for rapamycin; assay development.
Gallant
H L
HL
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
Yatscoff
R W
RW
D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007700:Kinetics; D007962:Leukocytes / Q000201:enzymology*; D008214:Lymphocytes / Q000201:enzymology*; D011090:Polyenes / Q000494:pharmacology*; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D019893:Ribosomal Protein S6 Kinases; D020123:Sirolimus; D013997:Time Factors
D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D017346:Protein Serine-Threonine Kinases; D019893:Ribosomal Protein S6 Kinases; D020123:Sirolimus